J Mesić - Concepedia

Concepedia

Author

J Mesić

RTOG Foundation

Also Known As

J B Mesic, J MESIC, J Mesic, J Mesić, J. Mesic, J.B. Mesic, John B Mesic, John B. Mesic, John Mesic

43

Publications

2.4K

Citations

10

H-Index

20

Concepts

All Affiliations

RTOG Foundation Medical College of Wisconsin Trinity Health Ann Arbor Hospital University of Pennsylvania LDS Hospital

JM

About

J Mesić is an author at RTOG Foundation specializing in radiation oncology, medicine, and radiation therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.6K
2	Health Sciences	1	1	38
3	Obstetrics	1	1	93
4	Pathology	1	1	265
5	Radiation Medicine	1	1	774

J Mesić

×

10

Publications

2.4K

Citations

10

H-Index

	Year	Citations
Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Miljenko V. Pilepich, Kathryn Winter, Madhu J. John, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation MedicineRadiation TherapyMedicineAndrogen Deprivation Adjuvant	2001	774
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. Miljenko V. Pilepich, Richard Caplan, Roger W. Byhardt, Journal of Clinical Oncology	1997	609
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate C.A. Lawton, Kathryn Winter, Kevin Murray, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation TherapyMedicineStandard Radiation TherapyProstatic Disease	2001	377
Megavoltage irradiation of epithelial tumors of the nasopharynx J Mesić, Gilbert H. Fletcher, Helmuth Goepfert International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineMegavoltage IrradiationNasopharyngeal CancerPathology	1981	265
p53 Status and Prognosis of Locally Advanced Prostatic Adenocarcinoma: a Study Based on RTOG 8610 David J. Grignon, F. H. Sarkar, J.D. Forman, JNCI Journal of the National Cancer Institute	1997	184
Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva Anthony H. Russell, J Mesić, Sidney Scudder, Gynecologic Oncology Vulvar DiseasesRadiation TherapyMedicineSynchronous RadiationGynecology	1992	93
The Value of Radiation Therapy as an Adjuvant to Surgery in Intracranial Meningiomas J Mesić, Gerald E. Hanks, R. L. Scotte Doggett American Journal of Clinical Oncology Neuro-oncologySkull BaseIntracranial MeningiomasRadiation TherapyBenign Meningiomas	1986	38
Prostate Cancer DNA Ploidy and Response to Salvage Hormone Therapy After Radiotherapy With or Without Short-Term Total Androgen Blockade: An Analysis of RTOG 8610 A. Pollack, David J. Grignon, Kateri Heydon, Journal of Clinical Oncology	2003	38
95 Phase III trial of adjuvant androgen suppression using goserelin in patients with carcinoma of the prostate treated with definitive radiotherapy (results of RTOG 85-31) M.V. Pilepich, Richard Caplan, Roger W. Byhardt, International Journal of Radiation OncologyBiologyPhysics Adjuvant Androgen SuppressionUrologyMedicinePhase Iii TrialBenign Prostatic Hyperplasia	1995	22
Androgen ablation adjuvant to defintive radiotherapy in carcinoma of the prostate: year 2000 update of RTOG phase III studies 86-10 and 85-31 M.V. Pilepich, K. Winter, Roger W. Byhardt, International Journal of Radiation OncologyBiologyPhysics UrologySurgical OncologyRadiation TherapyMedicineBrachytherapy	2000	10

Page 1